MLKL and amyotrophic lateral sclerosis: Another study holding the same view detected the expression of RIPK1, RIPK3, and MLKL (main components of necroptosis) in ALS patients and mouse models with mutant OPTN and SOD1, and concluded that the limitation of RIPK3 or RIPK1 protected ALS [42].